SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001651308-20-000222
Filing Date
2020-11-20
Accepted
2020-11-20 16:16:51
Documents
15
Period of Report
2020-11-19
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bgne-20201119.htm   iXBRL 8-K 49268
7 EX-99.1 ex991-8xk11x20x2020.htm EX-99.1 44025
  Complete submission text file 0001651308-20-000222.txt   253965

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bgne-20201119.xsd EX-101.SCH 2505
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bgne-20201119_cal.xml EX-101.CAL 793
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bgne-20201119_def.xml EX-101.DEF 1757
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bgne-20201119_lab.xml EX-101.LAB 25214
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bgne-20201119_pre.xml EX-101.PRE 13249
8 EXTRACTED XBRL INSTANCE DOCUMENT bgne-20201119_htm.xml XML 11810
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 981209416 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37686 | Film No.: 201332730
SIC: 2834 Pharmaceutical Preparations